A Phase 1, Open-Label, Multicenter, Dose-Escalation Study to Evaluate the Safety and Tolerability of SHR-1316 in Subjects with Advanced Solid Tumors

Project: Research

Status	Active
Effective start/end date	28/02/19 → 27/02/24